DRIO
DarioHealth Corp.Company Information
- Company Name
- DarioHealth Corp.
- CIK
- CIK0001533998
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- DRIO: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- DRIO
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-07-23
- Last sale
- —
- Shares purchased (TTM)
- 54,430
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 856,742
- Shares outstanding
- 9,343,618
- Ownership
- 9.17%
Earnings Market Reaction
- Filing date
- 2026-08-11
- Price on filing date
- —
- 1-month reaction
- -5.61%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 7 | 15 | 22 | 32 | 22 | 28 | 28 | 16 | 23 | 34 | 37 | 44 | ||||||
| Short Term Investments | 7 | 5 | - | - | - | - | - | - | - | - | - | - | ||||||
| Restricted Investments Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | ||||||
| Accounts And Other Receivables Net Current | 2 | 2 | 2 | 2 | 3 | 3 | 5 | 5 | 7 | 8 | 3 | 5 | ||||||
| Inventory Net | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Prepaid Expense And Other Assets Current | 3 | 2 | 2 | 3 | 3 | 3 | 2 | 3 | 4 | 4 | 2 | 2 | ||||||
| Assets Current | 22 | 29 | 35 | 42 | 32 | 39 | 41 | 30 | 39 | 53 | 47 | 56 | ||||||
Assets Noncurrent | ||||||||||||||||||
| Deposits Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | ||||||
| Property Plant And Equipment Net | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Intangible Assets Net Excluding Goodwill | 15 | 15 | 16 | 16 | 17 | 18 | 19 | 20 | 22 | 24 | 5 | 7 | ||||||
| Goodwill | 57 | 57 | 57 | 57 | 57 | 57 | 57 | 57 | 57 | 57 | 42 | 42 | ||||||
| Assets Noncurrent | 74 | 75 | 75 | 76 | 76 | 77 | 78 | 80 | 83 | 84 | 49 | 50 | ||||||
| Assets | 97 | 103 | 110 | 118 | 108 | 116 | 119 | 110 | 122 | 137 | 96 | 107 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Trade Current | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 1 | 2 | ||||||
| Contract With Customer Liability Current | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 2 | 1 | 1 | ||||||
| Operating Lease Liability Current | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | ||||||
| Other Accounts Payable And Accrued Liabilities | 5 | 5 | 5 | 5 | 5 | 4 | 6 | 6 | 6 | 7 | 6 | 5 | ||||||
| Long Term Debt Current | - | - | - | - | - | 10 | 5 | 9 | 5 | 4 | 4 | - | ||||||
| Liabilities Current | 10 | 9 | 9 | 9 | 10 | 19 | 17 | 19 | 17 | 18 | 12 | 8 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Operating Lease Liability Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Long Term Debt Noncurrent | 31 | 31 | 31 | 31 | 30 | 19 | 23 | 20 | 23 | 25 | 25 | 29 | ||||||
| Derivative Liabilities Noncurrent | 0 | 0 | 1 | 2 | 3 | 3 | 6 | 11 | 12 | 16 | 0 | 1 | ||||||
| Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities Noncurrent | 32 | 32 | 33 | 34 | 35 | 23 | 30 | 33 | 37 | 41 | 26 | 30 | ||||||
Statement Of Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 523 | 523 | 520 | 517 | 487 | 478 | 462 | 437 | 432 | 437 | 408 | 402 | ||||||
| Retained Earnings Accumulated Deficit | -468 | -460 | -452 | -442 | -423 | -404 | -390 | -378 | -363 | -359 | -349 | -334 | ||||||
| Stockholders Equity | 55 | 62 | 68 | 75 | 64 | 74 | 72 | 59 | 68 | 78 | 58 | 68 | ||||||
| Liabilities And Stockholders Equity | 97 | 103 | 110 | 118 | 108 | 116 | 119 | 110 | 122 | 137 | 96 | 107 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 400 | 400 | 400 | 400 | 160 | 160 | 400 | 160 | 160 | 160 | 160 | 160 | ||||||
| Common Stock Shares Issued | 7 | 7 | 7 | 7 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | ||||||
| Shares Outstanding | 7 | 7 | 7 | 7 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | ||||||
| Preferred Stock Par Or Stated Value Per Share | - | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | - | - | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Preferred Stock Shares Issued | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialDarioHealth Corp. (DRIO) — SEC Financial Statements & Analysis
DarioHealth Corp. (DRIO) is a surgical & medical instruments & apparatus company, incorporated in DE. DarioHealth Corp. trades on Nasdaq as: DRIO. DarioHealth Corp. (DRIO)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-11. Based on that filing, DarioHealth Corp. carries a market cap of $61.67M, a P/E ratio of 1.73x, a P/B ratio of 1.12x, a P/S ratio of 2.94x, an enterprise value of $86.10M, and an EV/EBITDA multiple of 2.68x. On profitability, it posts a gross margin of 58.15%, an operating margin of 151.60%, a net margin of 169.87%, a Return on Equity (ROE) of 59.91%, a Return on Assets (ROA) of 34.81%, and a Return on Invested Capital (ROIC) of 41.06%. Per share, it reports EPS of $3.82, diluted EPS of $3.82, free cash flow per share of $-2.73, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -22.65% year-over-year, net income growth of -19.26% year-over-year, and EPS growth of -78.56% year-over-year. On the balance sheet, it maintains a current ratio of 2.31x, a quick ratio of 1.65x, working capital of $12.55M, a debt-to-equity ratio of 0.75x, a debt ratio of 0.43, an interest coverage ratio of 6.02x, free cash flow of $-25.48M (TTM), and net debt of $24.43M. Figures sourced from SEC EDGAR.
- Market Cap
- $61.67M
- P/E TTM
- 1.73x
- EPS TTM
- $3.82
- P/B TTM
- 1.12x
- ROE TTM
- 59.91%
- ROA TTM
- 34.81%
- Debt To Equity
- 0.75x
- Free Cash Flow TTM
- $-25.48M
- Net Revenue TTM Growth 1Y
- -22.65%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is DarioHealth Corp. in?
DarioHealth Corp. (DRIO) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does DRIO trade on?
DarioHealth Corp. (DRIO) trades on the Nasdaq.
Where is DarioHealth Corp. incorporated?
DarioHealth Corp. is incorporated in DE.
When was DarioHealth Corp. (DRIO)'s most recent SEC filing?
DarioHealth Corp. (DRIO)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-11.
What is DRIO's market cap?
DarioHealth Corp. (DRIO) has a market capitalization of $61.67M as of 2026-06-30.
What is DRIO's P/E ratio?
DarioHealth Corp. (DRIO)'s trailing twelve month P/E ratio is 1.73x as of 2026-06-30.
What is DRIO's EPS (earnings per share)?
DarioHealth Corp. (DRIO)'s trailing twelve month EPS is $3.82 as of 2026-06-30.
What is DRIO's ROE (return on equity)?
DarioHealth Corp. (DRIO)'s trailing twelve month Return on Equity (ROE) is 59.91% as of 2026-06-30.
What is DRIO's ROA (return on assets)?
DarioHealth Corp. (DRIO)'s trailing twelve month Return on Assets (ROA) is 34.81% as of 2026-06-30.
What is DRIO's ROIC (return on invested capital)?
DarioHealth Corp. (DRIO)'s trailing twelve month Return on Invested Capital (ROIC) is 41.06% as of 2026-06-30.
What is DRIO's EV/EBITDA?
DarioHealth Corp. (DRIO)'s trailing twelve month EV/EBITDA is 2.68x as of 2026-06-30.